Cellebrite Di Stock Today
| CLBT Stock | USD 20.18 0.29 1.46% |
Performance11 of 100
| Odds Of DistressLess than 43
|
Cellebrite is selling for under 20.18 as of the 30th of November 2024; that is 1.46 percent increase since the beginning of the trading day. The stock's last reported lowest price was 19.97. Cellebrite has about a 43 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Cellebrite DI are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Software & Services | IPO Date 31st of August 2021 | Category Technology | Classification Information Technology |
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. Cellebrite operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. The company has 214.84 M outstanding shares of which 1.75 M shares are currently shorted by private and institutional investors with about 1.22 trading days to cover. More on Cellebrite DI
Moving together with Cellebrite Stock
Moving against Cellebrite Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Cellebrite Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Executive Chairman | Thomas Hogan | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Application Software, Software - Infrastructure, Information Technology, NASDAQ Composite, Information Technology, Software, Software—Infrastructure, Technology (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCellebrite can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cellebrite's financial leverage. It provides some insight into what part of Cellebrite's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellebrite DI (CLBT) is traded on NASDAQ Exchange in USA. It is located in 94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602 and employs 1,008 people. Cellebrite is listed under Application Software category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.34 B. Cellebrite DI conducts business under Software sector and is part of Information Technology industry. The entity has 214.84 M outstanding shares of which 1.75 M shares are currently shorted by private and institutional investors with about 1.22 trading days to cover.
Cellebrite DI currently holds about 142.51 M in cash with 102.06 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.
Check Cellebrite Probability Of Bankruptcy
Ownership AllocationCellebrite holds a total of 214.84 Million outstanding shares. Over half of Cellebrite's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cellebrite Ownership Details
Cellebrite Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Pembroke Management Ltd | 2024-09-30 | 1.9 M | |
| Ashford Capital Management Inc | 2024-06-30 | 1.9 M | |
| Blackrock Inc | 2024-06-30 | 1.9 M | |
| Crescent Park Management, L.p. | 2024-09-30 | 1.7 M | |
| Two Sigma Investments Llc | 2024-09-30 | 1.6 M | |
| Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Ltd | 2024-09-30 | 1.5 M | |
| Renaissance Technologies Corp | 2024-09-30 | 1.5 M | |
| Principal Financial Group Inc | 2024-09-30 | 1.4 M | |
| Goldman Sachs Group Inc | 2024-06-30 | 1.3 M | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 14 M | |
| True Wind Capital Management, L.p. | 2024-09-30 | 11.7 M |
Cellebrite Historical Income Statement
Cellebrite Stock Against Markets
Cellebrite Corporate Management
| Yossi Carmil | CEO Founder | Profile | |
| Zohar TadmorEilat | Chief Officer | Profile | |
| Osnat Tirosh | Chief Officer | Profile | |
| David Gee | Chief Officer | Profile | |
| Adam Jaffe | VP Communications | Profile | |
| Ayala Shapira | General Counsel | Profile |
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.